Business Context and Reporting Period
This Form 8-K Current Report from vTv Therapeutics Inc. (VTVT) covers the event date of November 20, 2023. The filing details the effective implementation of a reverse stock split approved by the Board of Directors on November 14, 2023.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The report focuses exclusively on corporate governance and capital structure adjustments.
Material Changes
- Reverse Stock Split: A 1-for-40 reverse stock split was effected at 4:01 p.m. Eastern Time on November 20, 2023.
- Share Consolidation: Every 40 shares of Class A and Class B common stock were combined into one issued and outstanding share.
- Fractional Shares: No fractional shares were issued; entitlements were rounded up to the nearest whole share.
- Stock Options: The number of shares issuable upon exercise of outstanding stock options was reduced proportionally.
- Trading Details: Post-split trading began on November 21, 2023, under the symbol "VTVT" with a new CUSIP number of 91835204.
Outlook, Risks, and Management Commentary
Purpose: The reverse stock split was executed to enable the Company to regain compliance with the Nasdaq Capital Market's minimum closing price requirement of $1.00 per share.
Forward-Looking Statements: The filing includes a disclaimer regarding statements about the Company's ability to maintain listing compliance. These statements are subject to risks and uncertainties, including those detailed in the Company's Form 10-K and subsequent Form 10-Q filings.
Ownership Impact: Each stockholder retains the same percentage of outstanding Class A and Class B common stock as held prior to the split, subject only to adjustments from fractional share rounding.
Investor Verification Checklist
- Verify the new CUSIP number (91835204) for Class A common stock in brokerage accounts.
- Confirm the adjusted number of shares held post-split, noting the rounding up of fractional shares.
- Review the adjusted strike prices and share counts for any outstanding stock options.
- Monitor the stock price on November 21, 2023, to assess if the $1.00 minimum listing requirement is met.
- Check subsequent filings for confirmation of continued Nasdaq Capital Market listing status.